After Tough 2011 For Chinese Healthcare IPOs, Policy And Cost Relief Could Be On The Way
This article was originally published in PharmAsia News
Executive Summary
China's pharma IPOs didn't meet the hype in 2011. Government action may now ease speculation mania.